Long-Term Prognosis Value of Paravalvular Leak and Patient–Prosthesis Mismatch following Transcatheter Aortic Valve Implantation: Insight from the France-TAVI Registry

Archive ouverte

Deharo, Pierre | Leroux, Lionel | Théron, Alexis | Ferrara, Jérôme | Vaillier, Antoine | Jaussaud, Nicolas | Porto, Alizée | Morera, Pierre | Gariboldi, Vlad | Iung, Bernard | Lefevre, Thierry | Commeau, Philippe | Gouysse, Margaux | Du Chayla, Florence | Glatt, Nicolas | Cayla, Guillaume | Le Breton, Hervé | Benamer, Hakim | Beurtheret, Sylvain | Verhoye, Jean-Philippe | Eltchaninoff, Hélène | Gilard, Martine | Collet, Jean Philippe | Dumonteil, Nicolas | Collart, Frederic | Modine, Thomas | Cuisset, Thomas

Edité par CCSD ; MDPI -

International audience. Background: Transcatheter aortic valve implantation (TAVI) is the preferred treatment for symptomatic severe aortic stenosis (AS) in a majority of patients across all surgical risks. Patients and methods: Paravalvular leak (PVL) and patient–prosthesis mismatch (PPM) are two frequent complications of TAVI. Therefore, based on the large France-TAVI registry, we planned to report the incidence of both complications following TAVI, evaluate their respective risk factors, and study their respective impacts on long-term clinical outcomes, including mortality. Results: We identified 47,494 patients in the database who underwent a TAVI in France between 1 January 2010 and 31 December 2019. Within this population, 17,742 patients had information regarding PPM status (5138 with moderate-to-severe PPM, 29.0%) and 20,878 had information regarding PVL (4056 with PVL ≥ 2, 19.4%). After adjustment, the risk factors for PVL ≥ 2 were a lower body mass index (BMI), a high baseline mean aortic gradient, a higher body surface area, a lower ejection fraction, a smaller diameter of TAVI, and a self-expandable TAVI device, while for moderate-to-severe PPM we identified a younger age, a lower BMI, a larger body surface area, a low aortic annulus area, a low ejection fraction, and a smaller diameter TAVI device (OR 0.85; 95% CI, 0.83–0.86) as predictors. At 6.5 years, PVL ≥ 2 was an independent predictor of mortality and was associated with higher mortality risk. PPM was not associated with increased risk of mortality. Conclusions: Our analysis from the France-TAVI registry showed that both moderate-to-severe PPM and PVL ≥ 2 continue to be frequently observed after the TAVI procedure. Different risk factors, mostly related to the patient’s anatomy and TAVI device selection, for both complications have been identified. Only PVL ≥ 2 was associated with higher mortality during follow-up.

Suggestions

Du même auteur

Predictors of Outcomes of Reintervention After Transcatheter Aortic Valve Replacement

Archive ouverte | Durand, Eric | CCSD

International audience. Background: In a context of extending transcatheter aortic valve replacement (TAVR) to patients with a longer life expectancy, it is important to better document the incidence and outcomes of...

Clinical effects of permanent pacemaker implantation after transcatheter aortic valve implantation: Insights from the nationwide FRANCE-TAVI registry

Archive ouverte | Auffret, Vincent | CCSD

International audience. BackgroundThe influence of permanent pacemaker implantation upon outcomes after transcatheter aortic valve implantation (TAVI) remains controversial.AimsTo evaluate the impact of permanent pa...

Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI

Archive ouverte | Auffret, Vincent | CCSD

International audience. Background - Transcatheter aortic valve replacement (TAVR) is standard therapy for patients with severe aortic stenosis who are at high surgical risk. However, national data regarding procedu...

Chargement des enrichissements...